Sign in
4

Changes in Ownership

Inogen Inc Filed Acc 0000950170-24-026541

EVP, R&D & Chief Med. Officer gave up 7,623 shares (to pay taxes)

  • EVP, R&D & Chief Med. Officer acquired 13,914 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Glezer Stanislav EVP, R&D & Chief Med. Officer 2024-03-01 Option exercise +13,914 23,729 D
Glezer Stanislav EVP, R&D & Chief Med. Officer 2024-03-01 Shares withheld for taxes −7,623 $7.03 $53,552 16,106 D
Derivatives
Glezer Stanislav EVP, R&D & Chief Med. Officer 2024-03-01 Option exercise · Restricted Stock Unit −768 4,612 D
Glezer Stanislav EVP, R&D & Chief Med. Officer 2024-03-01 Option exercise · Restricted Stock Unit −3,786 3,787 D
Glezer Stanislav EVP, R&D & Chief Med. Officer 2024-03-01 Option exercise · Restricted Stock Unit −9,360 18,719 D
Glezer Stanislav EVP, R&D & Chief Med. Officer 2024-03-01 Grant or award · Restricted Stock Unit +43,993 43,993 D
Loading xslF345X05/ownership.xml…